They sold it hard as it got close to breaking the $60 handle. Sellers are trying hard to keep it from that breakout area $60 1/2 shoul push it to $63 1/2 to test resistance.
Best drug company out there. The book wants to get shares on the cheap and sell them later the shorting has been lucrative. Nice consolidation period right now sellers are getting exhausted. Short trade will fail downside is limited upside is to $71 in the near term.
They are going to bid for BMY